Mayo Clinic and Thermo Fisher Scientific launched a joint venture May 19 to create diagnostic tests to manage a variety of conditions, the Post Bulletin reported.
The partnership aims to tackle conditions in areas including hematology, oncology, allergies and autoimmunity. Diagnostic tests will be jointly developed in Rochester, Minn.-based Mayo Clinic's Advanced Diagnostics Laboratory in One Discovery Square, a life science hub in Rochester.
"By pairing cutting-edge, innovative technologies with world-class clinical and diagnostic testing knowledge, this collaboration will ensure that the promising innovations are both clinically relevant and accessible globally," William Morice II, MD, PhD, chair of Mayo Clinic's department of laboratory medicine and pathology and president of Mayo Clinic Laboratories, said in a news release.
Dr. Morice told the Post Bulletin that a team of 12 to 15 people will be working on developing the tests under the partnership.
"We are excited to join forces with Mayo Clinic to accelerate access to precise and affordable diagnostics for patients across the globe," Gianluca Pettiti, senior vice president and president of specialty diagnostics at Thermo Fisher, said in the news release.
Read the full article here.